• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to secondary navigation

Before Header

Association of National Account Executives

Connect - Convene - Collaborate

  • About ANAE
    • Our Mission
    • Contact Us
  • News
    • Subscribe
    • Current Issue
    • Archive
  • Education & Content
    • Webinars
    • Blog
    • National Accounts University
    • Compensation Report
    • Whitepapers
  • Events
    • Events
    • Event Photos
  • Join ANAE
  • Login
  • About ANAE
    • Our Mission
    • Contact Us
  • News
    • Subscribe
    • Current Issue
    • Archive
  • Education & Content
    • Webinars
    • Blog
    • National Accounts University
    • Compensation Report
    • Whitepapers
  • Events
    • Events
    • Event Photos
  • Join ANAE
  • Login
  • Home
  • National Accounts Weekly
  • Events
  • Webinars
  • Join ANAE
  • Contact Us

As vaccine hopes rise, US races to buy syringes to avoid shortage scenario

As scientists race to develop a COVID-19 vaccine, some experts warned that syringes could become the next face masks – coveted items in short supply able to plunge the market into chaos.

But it appears that the federal government and health care supply companies learned a lesson from the mad scramble for masks and other personal protective equipment that came to symbolize the early weeks of the pandemic.

Rather than wait for a viable vaccine to stock up on syringes, the federal government is securing them now. To date, it has signed at least $260 million in contracts for their production.
Read More
Previous Post: « July 17, 2020
Next Post: PPE Safety Stock Planning: Prepare Now for Future Supply Disruption »
  • Home
  • National Accounts Weekly
  • Events
  • Webinars
  • Join ANAE
  • Contact Us

Copyright © 2026 Association of National Account Executives · All Rights Reserved · Powered by Mai Theme